-
Mashup Score: 0
The Duke-Margolis Institute for Health Policy, under a cooperative agreement with the U.S. Food and Drug Administration, is convening a one-day public virtual workshop focused on sharing effective strategies for dose-finding and optimization in rare diseases and best practices for early-phase trial design. Participants will discuss innovative trial designs, modeling, use of biomarkers, and other strategies that can lead to more efficient identification of appropriate drug dosages, as well as ways to individualize therapy based on comorbidities and age, particularly when faced with limited patient data. Discussion will also include consideration of the nuances of disease subtypes, population characteristics, therapy types, and specifics of drug administration and action.
Source: duke.zoom.usCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
The Duke-Margolis Institute for Health Policy, under a cooperative agreement with the U.S. Food and Drug Administration, is convening a one-day public virtual workshop focused on sharing effective strategies for dose-finding and optimization in rare diseases and best practices for early-phase trial design. Participants will discuss innovative trial designs, modeling, use of biomarkers, and other strategies that can lead to more efficient identification of appropriate drug dosages, as well as ways to individualize therapy based on comorbidities and age, particularly when faced with limited patient data. Discussion will also include consideration of the nuances of disease subtypes, population characteristics, therapy types, and specifics of drug administration and action.
Source: duke.zoom.usCategories: General Medicine News, Rare DiseaseTweet-
⏰ TOMORROW, OCT 29, @ 10 AM: Attend a FREE virtual workshop on drug development for #RareDiseases! 💊🔬Join @DukeMargolis & @FDA to discuss dosing, trial design, analytics, and more. Register now: https://t.co/AITnp6CcHE #RareDisease #DrugDevelopment #ClinicalTrials #Pharma
-
-
Mashup Score: 7
In October 2024, the Lancet Commission on Investing in Health is releasing “Global Health 2050,” a new roadmap to achieving dramatic gains in global health by mid-century. This landmark report builds on and updates the commission’s original report, Global Health 2035, which was published in 2013, as well as a second report (CIH 2.0) published five years later to mark the 40th anniversary of the Alma Ata declaration of “health for all. DGHI’s Center for Policy Impact in Global Health (CPIGH) served as the secretariat of the commission and provided seven of the report’s 50 authors. This Think Global panel will provide a broad overview of the report, which examines the feasibility of every nation reducing its premature mortality by half by 2050. The report identifies opportunities for investment in health that can succeed despite multiple headwinds, including rising geopolitical tensions and increasingly manifest climate change. Several of the report’s authors, including experts from CPIG
Source: duke.zoom.usCategories: General Medicine News, General HCPsTweet-
🗓️ Tomorrow, 12-1pm ET—we’ll have the @DukeGHI @DukeCPIGH launch of our @TheLancet Commission on Investing in Health report, “Global Health 2050” I’ll moderate—panelists: 🇳🇬Osondu Ogbuoji, Damope Fawole, Justina Seyi-Olajide 🇨🇳Simiao Chen 🇮🇸Omar Karlsson https://t.co/q3Iwb6mpxO https://t.co/9keRCAkJyN
-
-
Mashup Score: 1
Welcome! You are invited to join a meeting: Residency Meet and Greet . After registering, you will receive a confirmation email about joining the meeting.
Source: duke.zoom.usCategories: General Medicine News, NeurologyTweet-
RT @dukeneurores: Join us tomorrow for our Virtual Meet and Greet with the residents! https://t.co/x1ldJLq0Gs https://t.co/zf29ltyovu
-
-
Mashup Score: 5
In their new book, Dispatches From the AIDS Pandemic: A Public Health Story, Kevin De Cock, Harold Jaffe and James Curran – three former leaders with the U.S. Centers for Disease Control and Prevention – offer a compelling firsthand account of the earliest days of a global health crisis. In this Think Global event, the authors will share their experiences on the frontlines of the CDC’s efforts…
Source: duke.zoom.usCategories: General Medicine News, General HCPsTweet-
Two of the authors of this book are coming to @DukeGHI to give a talk tomorrow, which will stream online to the public The book offers "a compelling firsthand account of the earliest days of a global health crisis" Register at:https://t.co/b1CH8VCOYI https://t.co/JPUVN5Tr6v
-
-
Mashup Score: 10Erin Durham's Personal Meeting Room - Zoom - 3 year(s) ago
Elizabeth F. Msoka-Bright23:58I am Elizabeth Msoka-Bright from KCMC-KCRI Tanzania. I am so excited to join this workshop. Thank youGodfrey Bbosa30:24Hello everyone. Godfrey Bbosa, Dept of Pharmacology & Therapeutics, Makerere University College of Health Sciences, Kampala, UgandaGeoffrey Maiyoh38:50Intensified control in Bhutan lead to reduced burden and cost of malariaSasrubi S39:44Malaria…
Source: duke.zoom.usCategories: Healthcare Professionals, Latest HeadlinesTweet-
✍️Last year, I ran a 90-minute workshop for early career researchers at our partner universities worldwide on "How to write a research paper & get it published" 🖥️It is now online in case of interest ☺️ We haven't edited it or made it look pretty https://t.co/mrqg6e8yX2 1/2
-
-
Mashup Score: 7Erin Durham's Personal Meeting Room - Zoom - 3 year(s) ago
Chat Messages Godfrey Bbosa30:02Hello everyone. Dr. Godfrey Bbosa, Dept of Pharmacology & Therapeutics, Makerere University College of Health Sciences, Kampala, UgandaElizabeth F. Msoka-Bright33:36Good afternoon/evening everyone. My name is Elizabeth Msoka-Bright from Kilimanjaro Christian Medical Centre(KCMC)-Kilimanjaro Clinical Research Institute(KCRI), Moshi-Tanzania. I am happy to…
Source: duke.zoom.usCategories: Healthcare Professionals, Latest HeadlinesTweet-
🥹 I then ran a 60 minute workshop for the same early career researchers on "How to respond to peer reviewers' comments" 🖥️It is also online in case of interest ☺️ Again, we haven't edited it or made it look pretty https://t.co/AoZ9j22j7x 2/2
-
Opportunities to Improve Dose-Finding and Optimization for Rare Disease Drug Development https://t.co/bxnUbjiwOI